| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2029 |
| Trial ID | NCT03767725 |
| Disease | Multiple Myeloma |
| Altered gene | CD19|BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA/CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Anti-BCMA or/and Anti-CD19 cells Treatment of Relapsed Multiple Myeloma |
| Year | 2018 |
| Country | China |
| Company sponsor | Shenzhen Second People's Hospital |
| Other ID(s) | Weihong Chen06082018 |
| Cohort 1 | |||||||||||
|
|||||||||||